Therapeutic Effects of Gut Microbiota on Metabolic Syndrome: A Patent Review
CONCLUSION: Under the existing situation, the role of gastrointestinal microbiota as a therapeutic agent is becoming more utilized for treating human health issues and various metabolic syndromes including obesity, diabetes, and cardiovascular diseases. Understanding gut dysbiosis and associated complex interactions between microbes and hosts would be effective for designing future therapeutic interventions for metabolic syndrome. Our detailed patent analysis reflects that gut dysbiosis has a prominent role in metabolic syndromes and dietary therapeutic strategies can improve health by modulating the human microbiota, thei...
Source: Recent Patents on Food, Nutrition and Agriculture - March 21, 2022 Category: Food Science Authors: Shivani Singhal Vibha Rani Source Type: research